Sigilon TherapeuticsInc - Delisted Stock
Sigilon TherapeuticsInc is currently unavailable and cannot be used in your analysis. The information on this page reflects the last day Sigilon TherapeuticsInc was actively traded.
Valuation
Check how we calculate scores
Sigilon TherapeuticsInc Risk Profiles
Investors will always prefer to have the highest possible return on investment while minimizing volatility. Sigilon TherapeuticsInc market risk premium is the additional return an investor will receive from holding Sigilon TherapeuticsInc long position in a well-diversified portfolio. The market premium is part of the Capital Asset Pricing Model (CAPM), which most analysts and investors use to calculate the acceptable rate of return on investment in Sigilon TherapeuticsInc. At the center of the CAPM is the concept of risk and reward, which is usually communicated by investors using alpha and beta measures. Although Sigilon TherapeuticsInc's alpha and beta are two of the key measurements used to evaluate Sigilon TherapeuticsInc's performance over the market, the standard measures of volatility play an important role as well.
Mean Deviation | 14.23 | |||
Semi Deviation | 5.55 | |||
Standard Deviation | 54.44 | |||
Variance | 2964.07 |
View Sigilon TherapeuticsInc Related Equities
Risk & Return | Correlation |
Sigilon TherapeuticsInc Corporate Management
Elected by the shareholders, the Sigilon TherapeuticsInc's board of directors comprises two types of representatives: Sigilon TherapeuticsInc inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Sigilon. The board's role is to monitor Sigilon TherapeuticsInc's management team and ensure that shareholders' interests are well served. Sigilon TherapeuticsInc's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Sigilon TherapeuticsInc's outside directors are responsible for providing unbiased perspectives on the board's policies.
Philip AshtonRickardt | Chief Officer | Profile | |
MD MBA | Ex Officer | Profile | |
Arturo Vegas | CoFounder | Profile | |
Omid Veiseh | CoFounder | Profile | |
Daniel Anderson | CoFounder Board | Profile | |
MBA MD | CEO Pres | Profile |
Still Interested in Sigilon TherapeuticsInc?
Investing in delisted delisted stocks can be risky, as the stock is no longer traded on a public exchange and can therefore be difficult to sell. Delisting typically occurs when a company has failed to meet exchange requirements or has been acquired. Before investing, it's important to thoroughly research the company, including its financial health and prospects for the future, as well as the reasons for its delisting. Additionally, it may be difficult to find accurate and up-to-date information on the company and its stock.
Check out World Market Map to better understand how to build diversified portfolios. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in estimate. You can also try the Efficient Frontier module to plot and analyze your portfolio and positions against risk-return landscape of the market..
Other Consideration for investing in Sigilon Stock
If you are still planning to invest in Sigilon TherapeuticsInc check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Sigilon TherapeuticsInc's history and understand the potential risks before investing.
Portfolio Anywhere Track or share privately all of your investments from the convenience of any device | |
Earnings Calls Check upcoming earnings announcements updated hourly across public exchanges | |
Insider Screener Find insiders across different sectors to evaluate their impact on performance | |
Performance Analysis Check effects of mean-variance optimization against your current asset allocation | |
Fundamentals Comparison Compare fundamentals across multiple equities to find investing opportunities | |
Money Managers Screen money managers from public funds and ETFs managed around the world | |
Latest Portfolios Quick portfolio dashboard that showcases your latest portfolios | |
Economic Indicators Top statistical indicators that provide insights into how an economy is performing | |
My Watchlist Analysis Analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like | |
Idea Optimizer Use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio | |
Volatility Analysis Get historical volatility and risk analysis based on latest market data | |
Portfolio Manager State of the art Portfolio Manager to monitor and improve performance of your invested capital |